Phase-i-ii Study of Aclarubicin for Treatment of Acute Myeloid-leukemia

D. Machover,J. Gastiaburu,M. Delgado,Goldschmidt E,Hulhoven R,Misset Jl,F. Devassal,Haim Tapiero,Patricia Ribaud,Schwarzenberg L,Mathé G

Phase-i-ii Study of Aclarubicin for Treatment of Acute Myeloid-leukemia

1984

D. Machover
J. Gastiaburu
M. Delgado
Goldschmidt E
Hulhoven R
Misset Jl
F. Devassal
Haim Tapiero
Patricia Ribaud
Schwarzenberg L
Mathé G

4 refractory or relapse leukaemias treated. 17 in partial remission 40 leucemies refractaires ou en rechute ont ete traitees dont 17 ont ete mises en remission complete

Keywords:

Myeloid leukemia
Cancer research
Aclarubicin
Chemotherapy
Medicine
Toxicity
Mucositis
Progressive disease
Gastroenterology
Surgery
Induction chemotherapy
Daunorubicin
Regimen
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations